net sales of โฌ245 M (โฌ209 M for its 1Q 2009) and recurring EBITDA of โฌ38 M (โฌ14 M). Novecare reported significant improvement in profit driven by increased activity (volumes up by 18% year-on-year) across all regions, particularly in Asia. Volumes in the Industrial and the Agrochemical markets enjoy
โฆ LIBER โฆ
Novozymes Inc increases 2010 expectations after strong 1H 2010 performance
- Publisher
- Elsevier Science
- Year
- 2010
- Weight
- 52 KB
- Volume
- 2010
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Novozymes 1Q 2010: strong performance an
๐
Article
๐
2010
๐
Elsevier Science
โ 63 KB
Novozymes 1Q 2010: strong 1Q 2010 perfor
๐
Article
๐
2010
๐
Elsevier Science
โ 59 KB
## LS9 to produce biodiesel in Florida LS9, a renewable petroleum company, will revamp an existing fermentation plant in Okeechobee, FL, to allow production of its UltraClean Diesel and chemicals, initially at a demonstration scale, for ramp up to commercial scale. The plant, which the company rece
Novozymes Jan-Sep 2010: increased full-y
๐
Article
๐
2010
๐
Elsevier Science
โ 53 KB
## Lummus-BP license deal BP has granted Lummus Technology the exclusive licensing and marketing rights to its paraxylene recovery and isomerization process and catalysts. Lummus will handle all sales, marketing and licensing activities.
Novozymes Inc reports strong 3Q 2010 per
๐
Article
๐
2011
๐
Elsevier Science
โ 50 KB